Sympathomimetic medications: Nursing pharmacology

1,222views

Sympathomimetic medications: Nursing pharmacology

pharm

pharm

Pharmacokinetics - Absorption: Nursing pharmacology
Pharmacokinetics - Distribution: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Pharmacodynamics: Nursing pharmacology
Anthelmintics: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Beta lactam and beta lactamase inhibitor combinations: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antimalarials: Nursing pharmacology
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Medications for respiratory syncytial virus (RSV): Nursing pharmacology
Chloramphenicol: Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Insulin: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Antiglaucoma medications: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Iron preparations: Nursing pharmacology
Hemostatics: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Vaccines: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Analgesics for obstetrics: Nursing pharmacology
Ergot alkaloids: Nursing pharmacology
Neonatal eye prophylaxis: Nursing pharmacology
Lung surfactants and antenatal corticosteroids: Nursing pharmacology
Oxytocin: Nursing pharmacology
Phytonadione (Vitamin K1): Nursing pharmacology
Rho(D) immune globulin: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Tocolytics: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Mood stabilizers: Nursing pharmacology
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Angiogenesis inhibitors: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Plant extracts for chemotherapy: Nursing pharmacology
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Oxygen therapy: Nursing pharmacology

Notes





SYMPATHOMIMETIC MEDICATIONS, PART 1/2
DRUG NAME
dobutamine
dopamine
CLASS
Sympathomimetics
β1-agonist
β1- and α-agonist
MECHANISM of ACTION
Stimulates β1-adrenergic receptors → increases contractility and cardiac output
Stimulates β1-adrenergic receptors → increases contractility and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure
INDICATIONS
  • Cardiac decompensation
  • Unlabeled: cardiogenic shock in children
  • Shock
  • Hypotension
  • Unlabeled: bradycardia
  • Cardiac arrest
ROUTE(S) of ADMINISTRATION
  • IV
  • IV
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRAINDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications


SYMPATHOMIMETIC MEDICATIONS, PART 2/2
DRUG NAME
epinephrine (Adrenalin,
Adrenaclick, Epipen)

norepinephrine (Levophed)
isoproterenol (Isuprel)
CLASS
Sympathomimetics
Bronchodilator Nonselective adrenergic agonist
Nonselective
adrenergic agonist
Nonselective beta-adrenergic agonist
MECHANISM of ACTION
Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
Stimulates β-receptors in heart → increases contractility, heart rate, and cardiac output

Stimulates β1- and α-receptors → vasoconstriction → increases blood pressure

Stimulates β1- and β2-agonist →
bronchodilation, cardiac and CNS stimulation
INDICATIONS
  • Acute asthmatic attacks
  • Bronchospasm
  • Anaphylaxis, allergic reactions
  • Cardiac arrest
  • Shock
  • Acute hypotension
  • Shock
  • Episodes of heart block
  • Cardiac arrest, CPR
  • Bronchospasm occurring during anesthesia
  • Shock, congestive heart failure
ROUTE(S) of ADMINISTRATION
  • IV
  • IM
  • INH
  • ET tube
  • IV
  • IV
  • IM
SIDE EFFECTS
  • CV: palpitations, tachycardia, hypertension, angina, arrhythmias
  • GI: nausea, vomiting
  • CNS: cerebral hemorrhage
  • Dopamine, epinephrine, norepinephrine: extravasation (boxed warning), tissue necrosis, sloughing, gangrene
  • Epinephrine: hyperglycemia (clients with diabetes)
CONTRA-INDICATIONS & CAUTIONS
  • Pregnancy and breastfeeding
  • Elderly clients
  • Hypertension or coronary artery disease
  • Dobutamine
    • hypertrophic cardiomyopathy with outflow tract obstruction
  • Norepinephrine:
    • hypovolemia, mesenteric or peripheral thrombosis
  • Dopamine: 
    • tachyarrhythmias, ventricular fibrillation, pheochromocytoma, hypovolemia
  • Isoproterenol: 
    • tachyarrhythmias, angina pectoris, cardiac glycoside toxicity
  • Epinephrine:
    • closed-angle glaucoma, non-anaphylactic shock

Drug interactions:
  • Dobutamine: COMT inhibitors
  • Dopamine, epinephrine, norepinephrine: MAO inhibitors, TCAs
  • Combining sympathomimetic medications
NURSING CONSIDERATIONS for
SYMPATHOMIMETIC MEDICATIONS
ASSESSMENT & MONITORING

Assessment and monitoring - norepinephrine

Assessment
  • Weight
  • Orientation, LOC
  • Hemodynamic status
  • Respiratory status 

Intervention and monitoring
  • Administer via central line
  • Low dose titrated based on client’s response

Monitoring
  • Hemodynamic status
  • Intake and output
  • LOC
  • Side effects
    • Paresthesias, cool extremities
    • Extravasation
      • Stop infusion
      • Notify health care provider
      • Administer phentolamine mesylate subcutaneously
  • Evaluate for the therapeutic response of blood pressure stabilization.
CLIENT EDUCATION
  • Purpose of medication: increase their blood pressure
  • Administered as a continuous infusion, adjusted as needed
Author: Victoria S. Recalde, MD
Author: Kelsey LaFayette, BAN, RN
Illustrator: Elijah Lee, MScBMC

Transcript

Watch video only

Sympathomimetics are medications that mimic the effect of endogenous catecholamines, like norepinephrine and epinephrine. As a result, these medications activate the sympathetic nervous system, which in turn triggers the fight or flight response, ultimately increasing the heart rate and blood pressure, as well as slowing down digestion. This response maximizes blood flow to the muscles and brain.

Now, sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol. All of them are administered intravenously, while isoproterenol can also be given intramuscularly, and epinephrine can also be administered intramuscularly, as well as through endotracheal tube or inhalation.

Once administered, sympathomimetic medications act by stimulating adrenergic receptors. Now, there are two main groups of adrenergic receptors: the alpha receptors, and beta receptors. Alpha adrenergic receptors are mainly located on the walls of blood vessels of the skin, as well as the gastrointestinal and genitourinary systems, and when stimulated, they cause vasoconstriction and decreased blood flow to these tissues.

On the other hand, beta receptors have two main subtypes: beta-1 and beta-2. Beta-1 adrenergic receptors are mainly located in the heart, and when activated, they increase the heart rate and contractility, which helps pump out more blood. On the other hand, beta-2 adrenergic receptors are found on smooth muscle cells in the walls of blood vessels supplying skeletal muscles and the brain, so their activation leads to vasodilation and increased blood flow to these tissues; and in the lungs, they cause bronchodilation.

Each type of adrenergic agonists stimulate these receptors to a different degree, which makes them useful to treat different conditions. But in general, all of them activate beta-1 receptors, so they all increase heart contractility, helping in the treatment of conditions where the cardiac output is decreased.

Now, all of these medications can be used to treat cardiac decompensation and shock. In addition, dopamine can also be used to treat bradycardia and post-cardiac arrest after shock. Norepinephrine is mainly used to treat acute hypotension and shock. Epinephrine is used to treat cardiac arrest, shock, and anaphylactic reactions; and because of its action on beta-2 adrenergic receptors, it’s also useful to treat acute asthmatic attacks and bronchospasm. Finally, isoproterenol is used in the treatment of cardiac arrest, episodes of heart block, congestive heart failure, shock, and bronchospasm that may occur during anesthesia.

Now, most side effects of these medications are the result of their action on adrenergic receptors. Clients on sympathomimetics may also experience gastrointestinal side effects, such as nausea and vomiting. Sympathomimetics can also be associated with cardiovascular side effects, including hypertension, and tachycardia, while more serious side effects of adrenergic agonists include angina and arrhythmias, while excessive hypertension can even result in cerebral hemorrhage.

Dopamine, epinephrine, and norepinephrine have a boxed warning for extravasation, which can lead to tissue necrosis, sloughing, and gangrene. Finally, epinephrine can cause hyperglycemia in clients with diabetes.

As far as contraindications go, all sympathomimetic medications should be used with caution during pregnancy and breastfeeding, as well as in elderly clients and those with hypertension or coronary artery disease. In addition, dobutamine is contraindicated in clients with hypertrophic cardiomyopathy with outflow tract obstruction.

On the other hand, norepinephrine should be used with caution when there’s hypovolemia or mesenteric or peripheral thrombosis, and clients on this medication should have adequate blood volume to avoid reduced blood flow, ischemia, and tissue hypoxia from the vasoconstriction.

Dopamine is also contraindicated in clients with tachyarrhythmias, ventricular fibrillation, pheochromocytoma, and hypovolemia. Next, isoproterenol is contraindicated in clients with tachyarrhythmias or angina pectoris, as well as in those experiencing cardiac glycoside toxicity. Finally, epinephrine shouldn’t be given to clients with closed-angle glaucoma and those having a non-anaphylactic shock.

Key Takeaways

Sympathomimetic medications are drugs that mimic the effects of the sympathetic nervous system. They work by mimicking the effect of endogenous catecholamines, like norepinephrine and epinephrine, and can be used to treat conditions such as cardiac decompensation, shock, anaphylaxis, bronchospasm, and bradycardia post-cardiac arrest. Some common examples of sympathomimetic medications include dobutamine, dopamine, norepinephrine, epinephrine, and isoproterenol.

Once administered, these medications stimulate two types of adrenergic receptors, alpha, and beta. With alpha-adrenergic receptor stimulation, vasoconstriction occurs, whereas stimulation of beta-1 adrenergic receptors causes increased heart rate and contractility, and stimulation of beta-2 adrenergic receptors causes vasodilation and bronchodilation.

Common side effects of sympathomimetics include gastrointestinal disturbances, hypertension, and arrhythmias. Nursing considerations for clients receiving sympathomimetics include monitoring their hemodynamic status; titrating doses as needed; monitoring for side effects; and assessing for the desired therapeutic response. Client education is focused on what to expect during treatment.

Sources

  1. "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9 " LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
  5. "Shock - Classification and Pathophysiological Principles of Therapeutics. 15(2):102-113" Curr Cardiol Rev (2019)
  6. "Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis. 22(2):196-203" West J Emerg Med (2021 Feb 16)
  7. "Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis. 148(5):1307-1315" J Allergy Clin Immunol (2021 )